Engineering siRNA Lipid Nanoparticles for the Treatment of Mantle Cell Lymphoma
Mantle cell lymphoma (MCL) is an extremely difficult to treat subtype of non-Hodgkin lymphoma (NHL) with a low patient survival rate compared to most common cancers. Recently, nanoparticle delivery systems have received a great deal of interest for treating NHL. One of the more promising cargo optio...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
Research Showcase @ CMU
2017
|
| Subjects: | |
| Online Access: | http://repository.cmu.edu/dissertations/886 http://repository.cmu.edu/cgi/viewcontent.cgi?article=1925&context=dissertations |